

New Frontier Holdings Ltd (Company No. 12111072), trading as Frontier Botanics, is a UK-registered company with a wholly owned subsidiary in the Kingdom of Lesotho. We were established to build a vertically integrated medicinal cannabis platform from cultivation through processing to European market distribution.
We achieved operational status for a fraction of the capital consumed by comparable ventures, most of which no longer exist. That capital efficiency is our defining advantage.
Iain Richardson — CEO & Founder. Entrepreneurial background across multiple sectors. Hands-on operational leadership with deep knowledge of Lesotho and Southern African business. Direct oversight of all cultivation operations.
James Simpson — Finance Director. Financial management and corporate governance. Responsible for capital allocation, investor relations and financial modelling.
Dr Martin Burow — Medical Advisor. Medical doctor providing clinical oversight on pharmaceutical-grade production standards, regulatory compliance and product development.
Jonathan Roper — Legal Advisor. Solicitor ensuring corporate governance, shareholder protections and regulatory compliance across UK and Lesotho jurisdictions.


Everything you need to know about Frontier Botanics, our operations, and the investment opportunity.
Yes. Medical cannabis has been legal in the UK since November 2018 following changes introduced after high-profile cases like that of Alfie Dingley. However, access is tightly regulated and prescriptions are typically issued by specialist doctors. Frontier Botanics operates fully within UK and international legal frameworks to ensure compliance at every stage of production and distribution.
Lesotho was the first African nation to legalise medical cannabis cultivation and export, offering a stable regulatory environment, favourable climate, and cost-efficient production conditions. This allows Frontier Botanics to produce high-quality, pharmaceutical-grade cannabis at scale while maintaining competitive pricing for international markets.
Frontier Botanics focuses on vertically integrated operations—from cultivation in Lesotho to distribution in the UK—ensuring full control over quality, compliance, and supply chain efficiency. The company combines pharmaceutical standards with scalable infrastructure, positioning itself to meet growing demand in regulated global markets.
Frontier Botanics is currently raising capital to expand cultivation capacity, enhance processing facilities, and secure additional distribution partnerships. The funding round is designed to accelerate growth, increase production output, and strengthen the company’s position within the rapidly expanding global medical cannabis market.
The global medical cannabis market is projected to grow significantly over the coming decade, driven by increasing legalisation, patient demand, and clinical research. Countries across Europe—including the UK—are gradually expanding access, creating a strong long-term growth opportunity for early-stage, compliant operators like Frontier Botanics.
New Frontier Holdings Ltd
First Floor 690 Great West Road, Osterley Village, Isleworth, England TW7 4PU
Company No. 12111072
England & Wales
Frontier Botanics Lesotho (Proprietary) Limited, Morena Khoase Kolobe, Mohalalitoe Road Maseru, Kingdom of Lesotho
© 2026 New Frontier Holdings Ltd.